• For investors considering whether H.B. Fuller is currently priced attractively or if the recent share price leaves limited potential upside, this article focuses on what the current valuation suggests.
• The stock last closed at US$59.95, with a 12.1% return over the past year. However, recent 7-day and 30-day returns of 4.6% and 4.0% declines, along with a small 0.6% decline year to date, indicate that sentiment has been more cautious lately.
• Recent coverage has centered on how H.B. Fuller is positioned within the wider chemicals sector and what that might imply for capital allocation and portfolio positioning. This context helps explain why some investors are reassessing the balance between long-term compounding potential and shorter-term share price risk.
• The company currently has a valuation score of 2 out of 6. The next step is a walkthrough of the main valuation approaches used on H.B. Fuller and how they compare, followed by a way to assess value that goes beyond any single model.

H.B. Fuller scores just 2/6 on our valuation checks. See what other red flags we found in the full valuation breakdown.

Approach 1: H.B. Fuller Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow, or DCF, model estimates what a business might be worth by projecting its future cash flows and discounting them back to today, using a required rate of return. It is a way of asking what those future dollars are worth in present terms.

For H.B. Fuller, the model used is a 2 Stage Free Cash Flow to Equity approach based on cash flow projections. The latest twelve month free cash flow is about US$177.4 million. Analysts provide estimates for the next few years, and Simply Wall St extrapolates further to reach projected free cash flow of about US$210.2 million in 2035.

Pulling these yearly forecasts together and discounting them back results in an estimated intrinsic value of about US$56.80 per share. Compared with the recent share price of US$59.95, the model suggests the stock is around 5.5% overvalued. This is a relatively small gap and within a range where sentiment or assumptions can easily swing the conclusion.

Result: ABOUT RIGHT

H.B. Fuller is fairly valued according to our Discounted Cash Flow (DCF), but this can change at a moment's notice. Track the value in your watchlist or portfolio and be alerted on when to act.

Approach 2: H.B. Fuller Price vs Earnings

For profitable companies, the P/E ratio is a useful way to gauge what you are paying for each dollar of earnings. This makes it a straightforward cross check against the DCF result you saw earlier.

In general, higher growth expectations and lower perceived risk tend to support a higher “normal” or “fair” P/E ratio, while slower growth and higher risk usually point to a lower one. H.B. Fuller currently trades on a P/E of 20.45x. This sits below both the Chemicals industry average P/E of 30.00x and the peer group average of 30.90x, so the shares are not priced at the top end of the sector.

Simply Wall St’s Fair Ratio for H.B. Fuller is 18.99x. This is a proprietary estimate of what the P/E “should” be after accounting for factors such as earnings growth profile, industry, profit margins, market cap and specific risks. Because it blends these company specific characteristics, it can be more useful than a simple comparison with peers or the wider industry. Set against the current P/E of 20.45x, the shares screen as somewhat expensive on this measure.

Result: OVERVALUED

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 18 top founder-led companies.

Upgrade Your Decision Making: Choose your H.B. Fuller Narrative

Earlier it was mentioned that there is an even better way to understand valuation. Narratives on Simply Wall St help you attach a clear story to your numbers, linking what you think about H.B. Fuller’s future revenue, earnings and margins to a financial forecast, a fair value, and then a simple comparison with today’s price. This is all available within an easy tool on the Community page that updates as new news or earnings arrive and can reflect very different views. For example, one investor might build a Narrative around the highest analyst fair value of US$84.00 and another might use the lowest at US$58.00 to decide how the current share price of US$62.83 fits their own buy or sell thresholds.

Do you think there's more to the story for H.B. Fuller? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.